title: [Pharmacological therapy versus bariatric surgery for patients with obesity and type 2 diabetes].
abstract: There is strong epidemiological evidence for an association between increased body weight and a higher incidence of type 2 diabetes. Moreover, reduction in body weight may delay the onset of type 2 diabetes. The basic therapy of type 2 diabetes includes lifestyle modifications, such as education, nutritional advice, increased physical activity, non-smoking and strategies to cope with stress. If lifestyle modifications are not successful, antidiabetic pharmacotherapy is stepwise intensified to achieve individual therapeutic targets; however, pharmacological treatment of type 2 diabetes frequently fails to prevent the progress of the disease and the manifestation of diabetes complications. Sustained weight reduction belongs to the individual treatment targets for patients with obesity and type 2 diabetes. Because conservative weight reduction strategies are frequently not successful, bariatric surgery has emerged as an effective treatment particularly for those patients with obesity-associated type 2 diabetes in whom a glycosylated hemoglobin (HbA1c) target < 7.5% could not be achieved with pharmacological therapy. Bariatric surgery should no longer be considered as the last option for patients with obesity-associated type 2 diabetes.
authors: Department für Innere Medizin, Universität Leipzig, Liebigstr. 20, 04103, Leipzig, Deutschland, bluma@medizin.uni-leipzig.de.
authors: M
authors: M
authors: Blüher
mesh_terms: D050110:Bariatric Surgery / Q000706:statistics & numerical data*; D003131:Combined Modality Therapy / Q000706:statistics & numerical data; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents
references: Obes Rev. 2010 May;11(5):362-70
references: 19922430
references: N Engl J Med. 2014 May 22;370(21):2002-13
references: 24679060
references: JAMA. 2011 Jun 15;305(23):2419-26
references: 21666276
references: N Engl J Med. 2013 Jul 11;369(2):145-54
references: 23796131
references: Diabetologia. 2008 Sep;51(9):1752-4
references: 18504546
references: Diabet Med. 2011 Jun;28(6):628-42
references: 21480973
references: Arch Intern Med. 2008 Aug 11;168(15):1609-16
references: 18695074
references: Lancet. 1998 Sep 12;352(9131):854-65
references: 9742977
references: JAMA. 2003 Jan 1;289(1):76-9
references: 12503980
references: Eur J Endocrinol. 2014 Dec;171(6):R209-19
references: 25012199
references: Chirurg. 2014 Nov;85(11):957-62
references: 25323489
references: N Engl J Med. 2008 Jun 12;358(24):2545-59
references: 18539917
references: Diabetologia. 2011 Apr;54(4):864-8
references: 21174075
references: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004095
references: 15846698
references: Obes Surg. 2011 Apr;21(4):465-72
references: 21188546
references: Ann Intern Med. 1993 Oct 1;119(7 Pt 2):688-93
references: 8363198
references: Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E506-15
references: 20570822
references: Dtsch Med Wochenschr. 2012 Apr;137(15):802
references: 22492417
references: Dtsch Med Wochenschr. 2012 Apr;137(15):803
references: 22492418
references: N Engl J Med. 2008 Jun 12;358(24):2560-72
references: 18539916
references: Dtsch Arztebl Int. 2014 Oct 17;111(42):705-13
references: 25385482
references: N Engl J Med. 2012 Apr 26;366(17):1577-85
references: 22449317
references: JAMA. 2014 Sep 3;312(9):934-42
references: 25182102
references: JAMA. 2010 Jul 28;304(4):435-42
references: 20664044
references: JAMA. 2004 Sep 8;292(10):1188-94
references: 15353531
references: Surg Obes Relat Dis. 2010 May-Jun;6(3):254-9
references: 20303324
references: N Engl J Med. 1988 Feb 25;318(8):467-72
references: 3340128
references: N Engl J Med. 2006 Aug 24;355(8):763-78
references: 16926275
references: N Engl J Med. 2012 Apr 26;366(17):1635-6
references: 22449318
references: N Engl J Med. 2001 May 3;344(18):1343-50
references: 11333990
references: N Engl J Med. 2012 Aug 23;367(8):695-704
references: 22913680
references: Dtsch Med Wochenschr. 2014 May;139(21):1116-20
references: 24823981
references: N Engl J Med. 2009 Jul 30;361(5):445-54
references: 19641201
references: Lancet Oncol. 2009 Jul;10(7):653-62
references: 19556163
references: N Engl J Med. 2002 Feb 7;346(6):393-403
references: 11832527
references: JAMA. 2008 Jan 23;299(3):316-23
references: 18212316
references: Arch Surg. 2010 Jan;145(1):57-62
references: 20083755
references: N Engl J Med. 2007 Aug 23;357(8):741-52
references: 17715408
references: Diab Vasc Dis Res. 2013 Sep;10(5):397-409
references: 23711582
references: BMC Endocr Disord. 2014 Feb 01;14:9
references: 24484869
references: Ther Adv Chronic Dis. 2014 May;5(3):149-57
references: 24790729
references: Rev Diabet Stud. 2011 Fall;8(3):432-40
references: 22262079
references: Lancet. 2009 Nov 14;374(9702):1677-86
references: 19878986
references: Am J Med. 2010 Nov;123(11):1036-42
references: 20843498
references: N Engl J Med. 2012 Apr 26;366(17):1567-76
references: 22449319